The study of the amount of laser irradiation in photodynamic therapy for exudative age-related macular degeneration

The study of the amount of laser irradiation in photodynamic therapy for exudative age-related macular degeneration - The study of the amount of laser irradiation in photodynamic therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008816

Enrollment

Registered

2012-09-10

Start date

2012-05-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

age-related macular degeneration

Interventions

Standard-fluence photodynamic therapy Reduced-fluence photodynamic therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: treatment naive age-related macular degeneration with subfoveal choroidal neovascularization with visual acuity from 0.1 to 0.5

Exclusion criteria

Exclusion criteria: choroidal neovascularization secondary to pathological myopia and other disease

Design outcomes

Primary

Measure	Time frame
Variation on a logarithm of the minimum angle resolution of 12 months after the initial photodynamic therapy	—

Secondary

Measure	Time frame
To assess complication of 12 months after the initial photodynamic therapy and examine retinal angiography and retinal thickness	—

Countries

Japan

Contacts

Public ContactKenichi Mizukawa

Kawasaki Medical School Hospital Ophthalmology

mizu-p@med.kawasaki-m.ac.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026